Welcome to the
15th Annual Peptide Therapeutics Symposium

Dear Colleagues,

We welcome you all to our first virtual presentation of the 15th Annual Peptide Therapeutics Symposium. These unprecedented times required us to creatively adapt to the circumstances and we are excited that the live, virtual symposium has enabled our colleagues from around the globe to participate. While the program has departed from the format of prior years, we have continued our strong tradition of showcasing cutting-edge science.

This year’s 15th Annual Peptide Therapeutics Symposium will take place over two days and has been scheduled to align with the time zones of the speakers and poster presenters. The program opens with lectures by Dr. Kathryn Whitehead and Dr. Gregory Verdine, and includes Plenary lectures from Dr. Sarah Robertson and Dr. Glenn King. The Friday sessions feature talks by experts on molecular recognition, drug delivery, and novel avenues for drug and vaccine development.

We have worked hard with our colleagues at IU Conferences and the Salk Institute to take advantage of online opportunities for discussion and networking. The live streamed event will provide you with opportunities to ask questions and to have meaningful dialog with fellow attendees, poster presenters, and speakers from around the globe. There will break out rooms for interaction with poster presenters on Thursday morning and Friday afternoon. In addition, the taped presentations will be available for viewing for 30 days following the close of the meeting. A chat board will enable you to post questions for the speakers should they not have time to answer them during the Q&A session.

Thank you for joining us, we are grateful for your participation in the symposium. Your attendance as always is key to making this annual scientific event successful.

Sincerely,

Phil Dawson, Ph.D.
Chairman of the Board
Peptide Therapeutics Foundation

Soumitra Ghosh, Ph.D.
President
Peptide Therapeutics Foundation
   
Sponsors, Peptide Therapeutics Foundation
Astra Zeneca
Ferring Research Institute Inc.
Novo Nordisk
The PolyPeptide Group
Zealand Pharma